← Oscar Health, Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Net Income From Continuing Operations | — | — | ($609.6m) | ($270.6m) | $26.1m | ($442.9m) | |
| Net Income (Loss) Attributable to Parent | ($406.8m) | ($572.6m) | ($606.3m) | ($270.7m) | $25.4m | ($443.2m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($414.2m) | ($572.6m) | ($606.3m) | ($270.6m) | $26.1m | ($443.2m) | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($406.8m) | ($571.4m) | ($609.6m) | ($270.6m) | $26.1m | ($442.9m) | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $0 | $1.2m | ($3.3m) | $134k | $689k | $248k | |
| Depreciation, Depletion and Amortization | $11.3m | $14.6m | $15.3m | $30.7m | $32.1m | $28.9m | |
| Amortization of Debt Issuance Costs | $327k | $329k | $713k | $778k | $778k | $1.6m | |
| Amortization Of Securities | — | — | $2.5m | ($29.4m) | ($26.9m) | ($29.8m) | |
| Deferred Income Tax Expense (Benefit) | ($67k) | ($101k) | ($165k) | $58k | ($2.3m) | $2.4m | |
| Deferred Income Tax | — | — | ($165k) | $58k | ($2.3m) | $2.4m | |
| Deferred Tax | — | — | ($165k) | $58k | ($2.3m) | $2.4m | |
| Share-based Payment Arrangement, Noncash Expense | $35.9m | $86.3m | $112.3m | $159.7m | $109.8m | $87.7m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | $4.0m | |
| Share-based Payment Arrangement, Expense | $35.9m | $86.3m | $112.3m | $166.8m | $119.0m | $100.4m | |
| Gain (Loss) on Extinguishment of Debt | $0 | ($20.2m) | $0 | $0 | — | — | |
| Income Tax Expense (Benefit) | $1.0m | $846k | ($523k) | $3.3m | $7.3m | $5.6m | |
| Interest Expense Nonoperating | — | — | — | — | $23.7m | $17.6m | |
| Changes in operating assets and liabilities: | |||||||
| Additional Financial Items | |||||||
| Increase (Decrease) in Other Operating Assets | ($2.6m) | $9.4m | $243k | ($11.3m) | $11.5m | $27.1m | |
| General and Administrative Expense | $166.7m | $265.1m | $309.8m | $339.7m | $32.1m | $28.9m | |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | $368.8m | $1.7b | $3.4b | $4.7b | $7.4b | $10.1b | |
| Nonoperating Income (Expense) | — | — | — | ($7.1m) | ($105k) | ($23.3m) | |
| Proceeds from Contributions from Affiliates | — | — | $1.8m | $2.5m | $0 | $0 | |
| Proceeds from Issuance of Redeemable Preferred Stock | $375.7m | $0 | $0 | — | — | — | |
| Proceeds from Stock Options Exercised | $19.3m | $49.6m | $1.3m | $4.0m | $68.4m | $55.0m | |
| Beginning Cash Position | — | — | $1.1b | $1.6b | $1.9b | $1.6b | |
| Cash Flow From Continuing Financing Activities | — | — | $301.1m | $6.4m | $68.4m | $399.2m | |
| Cash Flow From Continuing Investing Activities | — | — | ($226.5m) | $577.2m | ($1.4b) | ($241.1m) | |
| Change In Account Payable | — | — | $280.2m | ($395.8m) | $133.1m | $167.7m | |
| Change In Other Current Assets | — | — | ($243k) | $11.3m | ($11.5m) | ($27.1m) | |
| Change In Payable | — | — | $1.0b | ($856.4m) | $634.5m | $1.2b | |
| Change In Payables And Accrued Expense | — | — | $1.0b | ($856.4m) | $634.5m | $1.2b | |
| Change In Receivables | — | — | ($551.1m) | $636.2m | ($177.5m) | $98.6m | |
| Change In Working Capital | — | — | $855.0m | ($192.1m) | $838.9m | $1.5b | |
| Changes In Account Receivables | — | — | ($541.9m) | $638.3m | ($164.7m) | $89.9m | |
| Changes In Cash | — | — | $454.9m | $311.5m | ($340.9m) | $1.3b | |
| End Cash Position | — | — | $1.6b | $1.9b | $1.6b | $2.8b | |
| Financing Cash Flow | — | — | $301.1m | $6.4m | $68.4m | $399.2m | |
| Free Cash Flow | — | — | $351.3m | ($297.7m) | $950.3m | $1.1b | |
| Gain Loss On Investment Securities | — | — | $1.3m | $70k | ($23k) | ($1.3m) | |
| Investing Cash Flow | — | — | ($226.5m) | $577.2m | ($1.4b) | ($241.1m) | |
| Issuance Of Capital Stock | — | $1.3b | $0 | $0 | — | — | |
| Net PPE Purchase And Sale | — | — | ($29.0m) | ($25.6m) | ($27.9m) | ($36.4m) | |
| Net Preferred Stock Issuance | — | $0 | $0 | — | — | — | |
| Operating Gains Losses | — | — | $1.3m | $70k | ($23k) | ($1.3m) | |
| Other Non Cash Items | — | — | $3.0m | $28.6m | ($300k) | ($10.7m) | |
| Preferred Stock Issuance | — | $0 | $0 | — | — | — | |
| Proceeds From Stock Option Exercised | — | — | $1.3m | $4.0m | $68.4m | $55.0m | |
| Purchase Of PPE | — | $25.9m | ($29.0m) | ($25.6m) | ($27.9m) | ($36.4m) | |
| Stock Based Compensation | — | — | $112.3m | $159.7m | $109.8m | $87.7m | |
| Gain (Loss) on Investments | $1.2m | $212k | ($1.3m) | — | — | — | |
| Other Operating Income (Expense), Net | — | — | $2.4m | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $222.7m | ($181.7m) | $380.3m | ($272.2m) | $978.2m | $1.1b | |
| Cash flows from investing activities: | |||||||
| Capital Expenditure | — | — | ($29.0m) | ($25.6m) | ($27.9m) | ($36.4m) | |
| Net Investment Purchase And Sale | — | — | ($198.6m) | $605.0m | ($1.4b) | ($209.0m) | |
| Purchase Of Investment | — | — | ($1.2b) | ($837.0m) | ($2.1b) | ($1.0b) | |
| Gain (Loss) on Sale of Investments | $1.2m | $209k | ($1.3m) | ($70k) | $23k | $1.3m | |
| Sale Of Investment | — | — | $994.1m | $1.4b | $770.0m | $805.0m | |
| Payments for (Proceeds from) Other Investing Activities | $0 | $0 | — | — | — | — | |
| Net Other Investing Changes | — | — | $1.1m | ($2.3m) | $3.9m | $4.3m | |
| Net Cash Provided by (Used in) Investing Activities | ($344.7m) | ($774.5m) | ($226.5m) | $577.2m | ($1.4b) | ($241.1m) | |
| Cash flows from financing activities: | |||||||
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $182.1m | $430.7m | $633.5m | $1.4b | $744.8m | $670.7m | |
| Proceeds from Issuance of Long-term Debt | $147.0m | $0 | $305.0m | $0 | $0 | $410.0m | |
| Issuance Of Debt | — | — | $305.0m | $0 | $0 | $410.0m | |
| Long Term Debt Issuance | — | — | $305.0m | $0 | $0 | $410.0m | |
| Net Issuance Payments Of Debt | — | — | $305.0m | $0 | $0 | $410.0m | |
| Net Long Term Debt Issuance | — | ($153.2m) | $305.0m | — | — | $410.0m | |
| Repayments of Long-term Debt | — | — | $0 | $0 | — | — | |
| Long Term Debt Payments | — | ($153.2m) | $0 | $0 | — | — | |
| Repayment Of Debt | — | ($153.2m) | $0 | $0 | — | — | |
| Common Stock Issuance | — | $1.3b | $0 | $0 | — | — | |
| Net Common Stock Issuance | — | $1.3b | $0 | $0 | — | — | |
| Payments for Repurchase of Common Stock | $0 | $0 | — | — | — | — | |
| Proceeds from Noncontrolling Interests | $0 | $7.2m | $0 | $0 | — | — | |
| Net Other Financing Charges | — | ($15.2m) | ($5.2m) | $2.5m | — | ($65.8m) | |
| Net Cash Provided by (Used in) Financing Activities | $611.7m | $1.2b | $301.1m | $6.4m | $68.4m | $399.2m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $489.7m | $282.5m | $454.9m | $311.5m | ($340.9m) | $1.3b | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $843.1m | $1.1b | $1.6b | $1.9b | $1.6b | $2.8b | |
| Supplemental disclosure of cash flow information: | |||||||
| Change In Cash Supplemental As Reported | — | — | $454.9m | $311.5m | ($340.9m) | $1.3b | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $0 | $4.3m | $10.1m | $23.2m | $33.7m | $12.8m | |
| Income Taxes Paid, Net | $1.5m | $697k | $1.9m | $2.4m | $674k | $17.5m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.